Health Care & Life Sciences » Biotechnology | Zhejiang Wolwo Bio Pharmaceutical Co. Ltd.

Zhejiang Wolwo Bio Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
190,589.20
238,206.50
265,994.80
310,842.40
382,964.60
498,023.10
Cost of Goods Sold (COGS) incl. D&A
7,719.80
10,130.30
13,833.40
12,678.50
14,583.30
32,523.50
Gross Income
182,869.40
228,076.20
252,161.40
298,163.90
368,381.30
465,499.60
SG&A Expense
101,783.80
115,520.80
124,781.10
150,007.20
164,336.60
213,068.40
EBIT
80,816.80
112,555.40
127,380.30
148,156.70
204,044.70
252,840.30
Unusual Expense
-
5,496.70
-
-
-
-
Non Operating Income/Expense
119.00
494.20
4,162.20
1,182.50
927.80
12,337.10
Pretax Income
83,110.90
118,878.20
138,616.20
151,832.10
218,969.20
272,982.30
Income Tax
12,559.80
19,329.50
20,799.60
22,631.10
32,865.30
41,118
Consolidated Net Income
70,551.10
99,548.60
117,816.60
129,201.00
186,103.90
231,864.20
Net Income
70,564.30
99,554.80
117,820.00
129,201.00
186,103.90
232,884.10
Net Income After Extraordinaries
70,564.30
99,554.80
117,820.00
129,201.00
186,103.90
232,884.10
Net Income Available to Common
70,564.30
99,554.80
117,820.00
129,201.00
186,103.90
232,884.10
EPS (Basic)
0.20
0.34
0.41
0.44
0.64
0.44
Basic Shares Outstanding
345,599.70
289,029.70
290,879.80
290,879.80
290,879.80
523,584.10
EPS (Diluted)
0.20
0.34
0.41
0.44
0.64
0.44
Diluted Shares Outstanding
345,599.70
289,029.70
290,879.80
290,879.80
290,879.80
523,584.10
EBITDA
84,443.00
116,728.00
131,996.60
154,370.40
210,566.80
260,198.20
Other Operating Expense
268.80
-
-
-
-
409.10
Non-Operating Interest Income
943.00
5,728.30
5,295.10
4,478.10
11,505.90
7,804.90
Minority Interest Expense
13.20
6.10
3.50
-
-
1,019.90

About Zhejiang Wolwo Bio Pharmaceutical Co.

View Profile
Address
No. 636 Zhiyuan North Road
Huzhou Zhejiang 313299
China
Employees -
Website http://www.wolwobiotech.com
Updated 07/08/2019
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of bio-pharmaceutical products. It primarily focuses on the diagnosis and treatment for allergic diseases. The company was founded on September 19, 2002 and is headquartered in Huzhou, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.